Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
August 2008
Features
Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures
Inadequately controlled asthma can be very debilitating and costly for patients. The authors emphasize the importance of tracking symptoms, and they recommend a combined strategy in which both patient and claims data are used to identify poor asthma control.
Tom James, MD, and Michael Fine, MD
Case Report
Low-Dose, Off-Label Drotrecogin Alfa (Xigris) in Severe Sepsis
A patient with multiple-organ failure recovered from septic shock when a low dose of drotrecogin alfa was administered.
Shan Wang, PharmD, Kristina Dabovic, PharmD, and Ruth S. Spector, MD
Meeting Highlights
American Society of Hypertension 23rd Annual Scientific Meeting and Exposition
Antihypertensive treatments include a dual receptor antagonist (PS433540) and a combination of amlodipine plus olmesartan (Azor).
Reuben B. David
Continuing Education Credit
The Pharmacological Management of Migraine, Part 2 Preventative Therapy
Part 2 of a two-part series summarizes treatments used to prevent migraine, the most common headache complaint in clinical practice. Current prophylactic therapies include selected beta blockers, antidepressants, anticonvulsant agents, NSAIDs, skeletal muscle relaxants, ACE-inhibitors, antipsychotic agents, antihistamines, botulinum, and herbal products.
George DeMaagd, PharmD, BCPS
Departments
Editorial
The Four-Way Win
David Nash, MD, MBA, describes the concept of "total leadership" and its value in helping people become more authentic, integrated, and creative.
David B. Nash, MD, MBA
Medication Errors
The Truth about Hospital Formularies, Part 1
In part 1 of a two-part article, Matthew Grissinger, RPh, FASCP, discusses widespread misconceptions about formularies among surveyed health care professionals.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Senate May Compromise on 'Biosimilars'
Stephen Barlas discusses the possible passage of a Senate bill that would allow the FDA to approve "near copies" of biotech agents ("biosimilars").
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From dronabinol to rosiglitazone, P&T presents the latest information about FDA approvals, new indications, recalls, and industry updates.
Drug Forecast
Combating Non-nucleoside Reverse Transcriptase Inhibitor Resistance with a Focus On Etravirine (Intelence) for HIV-1 Infection
The authors review etravirine (Intelence), a second-generation non-nucleoside reverse transcriptase inhibitor, for HIV-1 infection.
Nathaniel Eraikhuemen, PharmD, Angela M. Thornton, PharmD, Evans Branch III, PharmD, Sandrine T. Huynh, PharmD, and Candace Farley, PharmD
